A Single Center, Randomized, Placebo-Controlled, Double Blind, Parallel Group Study to Evaluate the Tolerability of a Single Dose of Abatacept 30 mg/kg Via Intravenous Infusion in Chinese SLE Subjects With Lupus Nephritis.
Phase of Trial: Phase I
Latest Information Update: 29 Jul 2013
At a glance
- Drugs Abatacept (Primary)
- Indications Lupus nephritis
- Focus Adverse reactions
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2010 Actual patient number changed from 9 to 13 as reported by ClinicalTrials.gov.
- 25 Oct 2009 New trial record.